GUT MICROBIOTA DYSBIOSIS IN RHEUMATIC DISEASES

Abstract

Rheumatic diseases, characterized by inflammation due to autoimmune processes, are widespread and often challenging to manage. Recent studies emphasize the role of gut microbiota dysbiosis in the pathogenesis of these conditions. Therefore, exploring the efficacy of gut microbiota modulation as a therapeutic strategy for rheumatic diseases is of significant interest.